ARCADIA Study

AtRial Cardiopathy and Antithrombotic Drugs in Prevention after Cryptogenic Stroke (ARCADIA)

Temporoparietal brain hemorrhage shown on an MRI scan

AGE: 45 years and older
SEX AT BIRTH: All
TYPE: Investigational Drug Study
CONDITION: Stroke
HEALTHY PARTICIPANTS: No
LOCATION: UH Cleveland Medical Center

Learn More About This Research Study

For more information, please contact study coordinator, Mary Andrews at 216-844-1800 and leave a message or complete the online form below.

Study Purpose

The purpose of this research study is to compare the effects (good and bad) of the ARCADIA study drugs (apixaban and aspirin) on the occurrence of silent strokes and memory loss after stroke.

Who Can Participate

Participants 45 years and older diagnosed with a stroke maybe eligible for this study.

Request More Information

Please complete the form below to be contacted by a study representative and learn more about this study.

Requestor's Information

XXX-XXX-XXXX

Study ID